The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use ...

Relacorilant, a selective glucocorticoid receptor modulator, provides sustained blood pressure control and metabolic benefits in patients with Cushing syndrome, according to a phase 3 trial.

A phenol peel, also called a phenol-croton oil peel, is a deep chemical resurfacing procedure used for etched facial lines and heavy sun damage, and it is ...